Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 3
2006 2
2007 1
2008 4
2009 4
2010 5
2011 5
2012 2
2013 2
2014 1
2015 1
2016 3
2017 5
2018 2
2019 3
2020 3
2021 4
2022 4
2023 5
2024 3
2025 6
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean gigante a (587 results)?
Les journées caribéennes des maladies rares et orphelines 2022.
Bellance R, Antolín Sanféliz I, Duclos S, Guiget-Valard AG, Inamo J, Signaté A, Allard-Saint-Albin O, Cantacouzéne M, Garófalo Gómez N, Sarrazin E. Bellance R, et al. Among authors: signate a. Med Sci (Paris). 2023 Nov;39 Hors série n° 1:67-71. doi: 10.1051/medsci/2023138. Epub 2023 Nov 17. Med Sci (Paris). 2023. PMID: 37975776 Free article. French. No abstract available.
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.
Adams D, Wixner J, Polydefkis M, Berk JL, Conceição IM, Dispenzieri A, Peltier A, Ueda M, Bender S, Capocelli K, Jay PY, Yureneva E, Obici L; patisiran Global OLE study group. Adams D, et al. JAMA Neurol. 2025 Mar 1;82(3):228-236. doi: 10.1001/jamaneurol.2024.4631. JAMA Neurol. 2025. PMID: 39804640 Free PMC article. Clinical Trial.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Free article. Clinical Trial.
Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study.
Péréon Y, Adams D, Camdessanché JP, Chanson JB, Cintas P, Magy L, Signaté A, Solé G, Svahn J, Tard C, Hababou C, Attarian S. Péréon Y, et al. Among authors: signate a. Orphanet J Rare Dis. 2025 Mar 1;20(1):95. doi: 10.1186/s13023-025-03589-4. Orphanet J Rare Dis. 2025. PMID: 40025610 Free PMC article.
Chikungunya, a Risk Factor for Guillain-Barré Syndrome.
Stegmann-Planchard S, Gallian P, Tressières B, Leparc-Goffart I, Lannuzel A, Signaté A, Laouénan C, Cabié A, Hoen B. Stegmann-Planchard S, et al. Among authors: signate a. Clin Infect Dis. 2020 Mar 3;70(6):1233-1235. doi: 10.1093/cid/ciz625. Clin Infect Dis. 2020. PMID: 31290540
Monozygotic twins with neuro-Behcet syndrome.
Bourgeois-Beauvais Q, Lobjois Q, Berthelot E, Signate A, Cabre P. Bourgeois-Beauvais Q, et al. Among authors: signate a. Rev Neurol (Paris). 2022 Apr;178(4):400-401. doi: 10.1016/j.neurol.2021.08.008. Epub 2021 Nov 14. Rev Neurol (Paris). 2022. PMID: 34785044 No abstract available.
Delay in Carotid Web Diagnosis Remains Common and Associated With an Increased Risk of Stroke Recurrence.
Poirette P, Chausson N, Papaxanthos J, Kyheng M, Labreuche J, Smadja D, Gaillard N, Signate A, Joux J, Obadia M, Renou P, Boyer A, Desilles JP, Boulanger M, Robinet-Borgomano E, Zhu F, Richard S, Turpinat C, Landais A, Desal H, Guillon B, Viguier A, Lamy M, Denier C, Lecluse A, Malrain C, Lyoubi A, Holay Q, Bourgeois Q, Chaari D, Olindo S, Marnat G; CAROWEB Investigators. Poirette P, et al. Among authors: signate a. Stroke. 2025 Aug;56(8):2091-2100. doi: 10.1161/STROKEAHA.124.050238. Epub 2025 May 12. Stroke. 2025. PMID: 40351183
Olfactory outcomes in Zika virus-associated Guillain-Barré syndrome.
Lazarini F, Lannuzel A, Cabié A, Michel V, Madec Y, Chaumont H, Calmont I, Favrat M, Montagutelli X, Roze E, Lledo PM; ZikaSmell Working Group. Lazarini F, et al. Eur J Neurol. 2022 Sep;29(9):2823-2831. doi: 10.1111/ene.15444. Epub 2022 Jun 30. Eur J Neurol. 2022. PMID: 35699338 Free article.
Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study.
Fargeot G, Echaniz-Laguna A, Labeyrie C, Svahn J, Camdessanché JP, Cintas P, Chanson JB, Esselin F, Piedvache C, Verstuyft C, Genestet S, Lagrange E, Magy L, Péréon Y, Sacconi S, Signate A, Nadaj-Pakleza A, Taithe F, Viala K, Tard C, Poinsignon V, Cauquil C, Attarian S, Adams D. Fargeot G, et al. Among authors: signate a. Amyloid. 2024 Mar;31(1):62-69. doi: 10.1080/13506129.2023.2270661. Epub 2023 Oct 19. Amyloid. 2024. PMID: 37855400
60 results